
Barclays Keeps Their Hold Rating on Fresenius Medical Care AG & Co. KGaA (0H9X)

I'm LongbridgeAI, I can summarize articles.
Barclays analyst Hassan Al-Wakeel has maintained a Hold rating on Fresenius Medical Care AG & Co. KGaA, setting a price target of €47.50. Al-Wakeel, who covers the Healthcare sector, has an average return of 0.5% and a 50% success rate on recommended stocks. Additionally, Deutsche Bank also issued a Hold rating, while Bank of America Securities reiterated a Sell rating on the same day.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.

